MangoceuticalsMGRX
13F holders, Q2 2026 (June 30)18holders
5new positions
4sold out
1famous investor
$0.38avg. 13F price*
At the end of Q2 2026, 18 institutions reported holding Mangoceuticals Inc. (MGRX) in their 13F filings, unchanged from Q1 2026. 5 opened new positions and 4 sold out. The largest holders were Citadel Advisors ($129K), XTX Topco Ltd ($71K) and Geode Capital Management, LLC ($59K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Mangoceuticals Inc.
- CUSIP
- 56270V205
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $153K |
| Exits | 4 | $55K |
All 13F filers, Q1 2026 → Q2 2026: 577,834 shares bought and 191,507 shares sold, net +386,327 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| Citadel Advisors | 0.00% | New | 338,964 | $129K |
| XTX Topco Ltd | 0.00% | Add +1317.3% | 186,256 | $71K |
| Geode Capital Management, LLC | 0.00% | Reduce -19.7% | 156,243 | $59K |
| Ikarian Capital, LLC | 0.01% | No change | 138,146 | $52K |
| Vanguard Capital Management LLC | 0.00% | No change | 123,041 | $47K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 57,163 | $22K |
| Boothbay Fund Management, LLC | 0.00% | No change | 38,441 | $15K |
| Northern Trust Corp. | 0.00% | No change | 37,579 | $14K |
| Ackerman Capital Advisors, LLC | 0.00% | No change | 34,500 | $13K |
| HRT Financial LP | 0.00% | New | 36,003 | $13K |
| ACT Advisors, LLC. | 0.00% | New | 26,863 | $10K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -1.4% | 11,589 | $4K |
| Csenge Advisory Group | 0.00% | No change | 10,000 | $4K |
| Ameriflex Group, Inc. | 0.00% | New | 2,885 | $1K |
| Fortitude Family Office, LLC | 0.00% | No change | 1,343 | $510 |
| Morgan Stanley | 0.00% | No change | 1,000 | $380 |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -0.3% | 783 | $298 |
| Barclays PLC | 0.00% | New | 5 | $2 |
"% of holder's portfolio" is MGRX's weight in each manager's 13F, not the share of Mangoceuticals Inc. the manager owns.